Remarks: The U.S. Department of Defense is supporting creation of a small, portable device that safely sends vaccines and therapies through the skin. The device is being developed by Inovio Pharmaceuticals Inc. in Plymouth Meeting, Pennsylvania, and funded by an $8.14 million award from DoD’s Medical CBRN Defense Consortium; CBRN stands for Chemical, Biological, Radiological, and Nuclear threats. FULL STORY HERE: https://www.4cmitv.com/2020/09/26/2019-jun-10-dod-funding-vaccine-therapy-delivery-device/
SCIENCE AND ENTERPRISE HEADLINES: DoD Funding Vaccine, Therapy Delivery Device
Inovio Pharmaceuticals is a developer of vaccines and therapies for infectious diseases and cancer, licensing discoveries from the lab of immunologist David Weiner, now director of the Wistar Institute’s Vaccine Center and previously at University of Pennsylvania. Weiner and colleagues are seeking faster and easier methods to make vaccinations protecting against infectious diseases.
In this process, called DMab — short for DNA monoclonal antibody — DNA fragments are ingested into cells, where they’re exposed to 3 to 4 mild electrical pulses. Inovio calls this electronic assistance its Cellectra system that increases the uptake of DNA to generate more antibodies.
FILE SIZE: 202 kb
Hashtags: #4cminewswire, #DoD, #InovioPharmaceuticals, #CBRN, #Chemical, #Biological, #Radiological, #Nuclear, #COVID19, #Covid19Vaccines, #Vaccines, #CarrieMadej, #4cminews, #4CMiTV, #4CM2020JUN10,
Tags: 4cminewswire, DoD, Inovio Pharmaceuticals, CBRN, Chemical Biological Radiological Nuclear, COVID-19, COVID-19 Vaccines, Vaccines, Carrie Madej, 4cminews, 4CMiTV, #4CM2020JUN10,